52 research outputs found
Development of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 System
In spite of the enormous potential of CRISPR/Cas in basic and applied science, the levels of
undesired genomic modifications cells still remain mostly unknown and controversial. Nowadays,
the efficiency and specificity of the cuts generated by CRISPR/Cas is the main concern. However,
there are also other potential drawbacks when DNA donors are used for gene repair or gene knock-ins.
These GE strategies should take into account not only the specificity of the nucleases, but also
the fidelity of the DNA donor to carry out their function. The current methods to quantify the
fidelity of DNA donor are costly and lack sensitivity to detect illegitimate DNA donor integrations.
In this work, we have engineered two reporter cell lines (K562_SEWAS84 and K562GWP) that
efficiently quantify both the on-target and the illegitimate DNA donor integrations in a WAS-locus
targeting setting. K562_SEWAS84 cells allow the detection of both HDR-and HITI-based donor
integration, while K562GWP cells only report HDR-based GE. To the best of our knowledge, these are
the first reporter systems that allow the use of gRNAs targeting a relevant locus to measure efficacy
and specificity of DNA donor-based GE strategies. By using these models, we have found that the
specificity of HDR is independent of the delivery method and that the insertion of the target sequence
into the DNA donor enhances efficiency but do not affect specificity. Finally, we have also shown that
the higher the number of the target sites is, the higher the specificity and efficacy of GE will be.Spanish ISCIII Health Research FundEuropean Union (EU)
PI15/02015
PI18/00337
PI18/00330CECEyU of the Junta de Andalucia FEDER/European Cohesion Fund (FSE)
2016000073391-TRA
2016000073332-TRA
PI-57069
CARTPI-0001-201
PAIDI-Bio326
PI-0014-2016CSyF of the Junta de Andalucia FEDER/European Cohesion Fund (FSE)
2016000073391-TRA
2016000073332-TRA
PI-57069
CARTPI-0001-201
PAIDI-Bio326
PI-0014-2016Nicolas Monardes regional Ministry of Health contract
0006/2018Fundacion Poco FrecuenteSpanish Government
FPU17/04327
FPU17/02268ISCIII through a PFIS fellowship
FI19/00163SMSI
PEJ-2018-001760-
Genome-edited adult stem cells: Next-generation advanced therapy medicinal products
Over recent decades, gene therapy, which has enabled the treatment of several incurable
diseases, has undergone a veritable revolution. Cell therapy has also seen major advances
in the treatment of various diseases, particularly through the use of adult stem cells
(ASCs). The combination of gene and cell therapy (GCT) has opened up new opportunities to improve advanced therapy medicinal products for the treatment of several diseases. Despite the considerable potential of GCT, the use of retroviral vectors has major
limitations with regard to oncogene transactivation and the lack of physiological expression. Recently, gene therapists have focused on genome editing (GE) technologies as an
alternative strategy. In this review, we discuss the potential benefits of using GE technologies to improve GCT approaches based on ASCs. We will begin with a brief summary of
different GE platforms and techniques and will then focus on key therapeutic approaches
that have been successfully used to treat diseases in animal models. Finally, we discuss
whether ASC GE could become a real alternative to retroviral vectors in a GCT setting.European Regional Development Fund
(FEDER), Grant/Award Numbers: PI18/01610,
PI18/00330, PI18/00337, grants PI12/01097;
Spanish ISCIII Health Research Fun
Efeito da nutrição enteral precoce na mortalidade em doentes críticos com COVID-19
Background: Early enteral nutrition (EEN) has shown favorable clinical outcomes, such as lower risk of death, fewer frequency of infection and lower healthcare costs. Different societies recommend the provision of enteral nutrition within the first 24 to 48 hours of admission to the Intensive Care Unit in patients with COVID-19.
Methods: Retrospective cohort study including adult patients with severe COVID-19 and orotracheal intubation. Demographic and clinical characteristics, as well as use of drugs with nutritional relevance, such as vasopressors and steroids, as well as biochemical results (serum electrolytes) were registered. EEN was defined as the provision of enteral feeding within the first 24-48 hours of invasive mechanical ventilation (IMV). The primary outcome was in-hospital all-cause mortality.
Results: Overall, 404 patients were included in the study. EEN was achieved in 74% of all patients. EEN significantly reduced mortality in the bivariate model (RR 0.88, 95% CI 0.80 - 0.95) and in the multivariate model (adjusted OR 0.42, 95% CI 0.19 – 0.90). No differences in hospital length of stay and days on IMV in survivors were found.
Conclusions: EEN was associated with a lower risk of death in critically ill patients with COVID-19. Additional studies are necessary to further clarify the effects of early enteral feeding on patient outcomes. Antecedentes: la nutrición enteral temprana ha demostrado resultados clínicos favorables, tales como menor riesgo de mortalidad, menor frecuencia de infecciones y menores costos en salud. Diferentes sociedades recomiendan la provisión de nutrición enteral dentro de las primeras 24 a 48 horas del ingreso a la unidad de cuidados intensivos (UCI) en pacientes con enfermedad por coronavirus de 2019 (COVID-19).
Métodos: estudio de cohorte retrospectiva en pacientes adultos con COVID-19 grave e intubación orotraqueal. Se registraron las características demográficas y clínicas, así como el uso de fármacos con relevancia nutricional, como vasopresores y corticoides, y los resultados bioquímicos (electrolitos séricos). La nutrición enteral temprana se definió como la provisión de alimentación enteral en las primeras 24-48 horas de ventilación mecánica invasiva. El resultado primario fue la mortalidad hospitalaria por todas las causas.
Resultados: se incluyeron en el análisis a 404 pacientes. El 74 % de los casos recibió nutrición enteral temprana. La nutrición enteral temprana se asoció con una reducción estadísticamente significativa en la mortalidad por todas las causas en el modelo bivariado (riesgo relativo [RR]: 0,88; intervalo de confianza [IC] del 95 %: 0,80 a 0,95) y en el modelo multivariado ajustado (odds ratio [OR] ajustado: 0,42; IC 95 %: 0,19 a 0,90). No se encontraron diferencias significativas en la duración de la estancia hospitalaria ni en los días de VMI en los supervivientes.
Conclusiones: la nutrición enteral temprana se asocia con menor mortalidad por todas las causas en pacientes críticos con COVID-19. Son necesarios estudios adicionales para aclarar los efectos de la nutrición enteral temprana en los resultados de los pacientes. Introdução: a nutrição enteral precoce (NEP) tem mostrado resultados clínicos favoráveis, como menor risco de morte, menor frequência de infecção e menores custos de saúde. Diferentes sociedades recomendam o fornecimento de nutrição enteral nas primeiras 24 a 48 horas após a admissão na Unidade de Terapia Intensiva em pacientes com COVID-19.
Métodos: estudo de coorte retrospectivo incluindo pacientes adultos com COVID-19 grave e intubação orotraqueal. Foram registradas as características demográficas e clínicas, bem como o uso de medicamentos com relevância nutricional, como vasopressores e esteróides, e os resultados bioquímicos (eletrólitos séricos). A NEP foi definida como o fornecimento de alimentação enteral nas primeiras 24-48 horas de ventilação mecânica invasiva (VMI). O desfecho primário foi mortalidade intra-hospitalar por todas as causas.
Resultados: quatrocentos e quatro pacientes foram incluídos no estudo. A NEP foi alcançada em 74% de todos os pacientes. A NEP reduziu significativamente a mortalidade no modelo bivariado (RR 0,88, 95% IC 0,80 a 0,95) e no modelo multivariado (OR ajustado 0,42, 95% IC 0,19 – 0,90). Não foram encontradas diferenças no tempo de internação e nos dias de VMI nos sobreviventes.
Conclusões: a NEP foi associada a menor risco de morte em pacientes gravemente doentes com COVID-19. Estudos adicionais são necessários para esclarecer melhor os efeitos da alimentação enteral precoce nos resultados dos pacientes.
Desarrollo de una metodología voltamperométrica para la determinación de Aflatoxina B1 usando un electrodo de carbón vítreo modificado con una película de bismuto y nanopartículas de oro
La Aflatoxina B1 es una micotoxina altamente cancerígena que se encuentra en una gran variedad de alimentos y piensos, por lo tanto, su cuantificación es importante para la industria de los alimentos. En este trabajo de investigación se describe el desarrollo de una metodología electroanalítica utilizando un electrodo de carbón vítreo modificado superficialmente con una película de bismuto y nanopartículas de oro para la cuantificación de Aflatoxina B1, por las ventajas que presenta frente a otras metodologías que ya se han estudiado y validado para la cuantificación de esta sustancia. Los límites de detección y de cuantificación que se obtuvieron después de la de la optimización de la Voltamperometría de Onda Cuadrada mediante un diseño Box-Behnken fueron 11.19 y 37.31 ng L-¹, respectivamente. Estos parámetros nos indican que es posible cuantificar la aflatoxina B1 en un intervalo de concentraciones a nivel traza, tal como se encuentra en alimentos.feeds, therefore, its quantification is important for the food industry. This research paper describes the development of an electroanalytical methodology using a glassy carbon electrode modified with a bismuth film and gold nanoparticles for quantification of Aflatoxin B1, due to the advantages it presents over other methodologies that have already been studied and validated for the quantification of this substance. The detection and quantification limits obtained after optimization of Square Wave Voltammetry using a Box-Behnken design were 11.19 and 37.31 ng L-¹, respectively. These parameters indicated that it is possible to quantify the Aflatoxin B1 in a wide concentration range at trace levels, as expected in food
Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies
Pompe disease (PD) is a rare disorder caused by mutations in the acid alpha-glucosidase
(GAA) gene. Most gene therapies (GT) partially rely on the cross-correction of unmodified cells
through the uptake of the GAA enzyme secreted by corrected cells. In the present study, we generated
isogenic murine GAA-KO cell lines resembling severe mutations from Pompe patients. All of the
generated GAA-KO cells lacked GAA activity and presented an increased autophagy and increased
glycogen content by means of myotube differentiation as well as the downregulation of mannose
6-phosphate receptors (CI-MPRs), validating them as models for PD. Additionally, different chimeric
murine GAA proteins (IFG, IFLG and 2G) were designed with the aim to improve their therapeutic
activity. Phenotypic rescue analyses using lentiviral vectors point to IFG chimera as the best candidate
in restoring GAA activity, normalising the autophagic marker p62 and surface levels of CI-MPRs.
Interestingly, in vivo administration of liver-directed AAVs expressing the chimeras further confirmed
the good behaviour of IFG, achieving cross-correction in heart tissue. In summary, we generated
different isogenic murine muscle cell lines mimicking the severe PD phenotype, as well as validating
their applicability as preclinical models in order to reduce animal experimentation.Fundacion Poco Frecuente (Almeria)Asociacion Espanola de Enfermos de Glucogenosis (AEEG)Asociacion Espanola de Enfermos de Pompe (AEEP
Physiological lentiviral vectors for the generation of improved CAR-T cells
Anti-CD19 chimeric antigen receptor (CAR)-T cells have
achieved impressive outcomes for the treatment of relapsed
and refractory B-lineage neoplasms.However, important limitations
still remain due to severe adverse events (i.e., cytokine
release syndrome and neuroinflammation) and relapse of
40%–50%of the treated patients.MostCAR-Tcells are generated
using retroviral vectors with strong promoters that lead to high
CAR expression levels, tonic signaling, premature exhaustion,
and overstimulation, reducing efficacy and increasing side effects.
Here, we show that lentiviral vectors (LVs) expressing the
transgene through a WAS gene promoter (AW-LVs) closely
mimic the T cell receptor (TCR)/CD3 expression kinetic upon
stimulation. These AW-LVs can generate improved CAR-T cells
as a consequence of theirmoderate andTCR-like expression profile.
Compared with CAR-T cells generated with human elongation
factor a (EF1a)-driven-LVs, AW-CAR-T cells exhibited
lower tonic signaling, higher proportion of naive and stem cell
memory T cells, less exhausted phenotype, and milder secretion
of tumor necrosis factor alpha (TNF-a) and interferon (IFN)-ɣ
after efficient destruction of CD19+ lymphoma cells, both
in vitro and in vivo.Moreover, we also showed their improved efficiency
using an in vitro CD19+ pancreatic tumor model. We
finally demonstrated the feasibility of large-scale manufacturing
ofAW-CAR-T cells in good manufacturing practice (GMP)-like
conditions. Based on these data, we propose the use of AW-LVs
for the generation of improved CAR-T products.Spanish ISCIII Health Research FundEuropean Commission PI15/02015
PI18/00337
PI21/00298
RD21/0017/0004
PI18/00330
PI17/00672CSyF of the Junta de Andalucia FEDER/European Cohesion Fund (FSE) for Andalusia 2016000073391-TRA
2016000073332-TRA
PI-57069
PA IDI-Bio326
CARTPI-0001-201
PECART-0031-2020
Red RANTECAR CAR-T 2019 00400200101918
PLEC2021-008094
PI-0014-2016
PEER-0286-2019Spanish Government PLEC2021-008094
00123009/SNEO-20191072Nicolas Monardes contracts from regional Ministry of Health 0006/2018
C2-0002-2019German Research Foundation (DFG) FPU16/05467
FPU17/02268
FPU17/04327
MCI DIN2018-010180Fundacion Andaluza Progreso y SaludGerman Research Foundation (DFG) PEJ-2018-001760-AJunta de Andalucia PE-0223-2018Biomedicine Programme of the University of Granada (Spain
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
Controlling transgene expression through an externally
administered inductor is envisioned as a potent strategy
to improve safety and efficacy of gene therapy approaches.
Generally, inducible ON systems require a chimeric transcription
factor (transactivator) that becomes activated by
an inductor, which is not optimal for clinical translation
due to their toxicity. We generated previously the first
all-in-one, transactivator-free, doxycycline (Dox)-responsive
(Lent-On-Plus or LOP) lentiviral vectors (LVs) able to control
transgene expression in human stem cells. Here, we
have generated new versions of the LOP LVs and have
analyzed their applicability for the generation of inducible
advanced therapy medicinal products (ATMPs) with special
focus on primary human T cells. We have shown that, contrary
to all other cell types analyzed, an Is2 insulator must
be inserted into the 30 long terminal repeat of the LOP
LVs in order to control transgene expression in human
primary T cells. Importantly, inducible primary T cells
generated by the LOPIs2 LVs are responsive to ultralow
doses of Dox and have no changes in phenotype or function
compared with untransduced T cells. We validated
the LOPIs2 system by generating inducible CAR-T cells
that selectively kill CD19+ cells in the presence of Dox.
In summary, we describe here the first transactivatorfree,
all-one-one system capable of generating Dox-inducible
ATMPs.Spanish ISCIII Health Research FundEuropean Union (EU) PI18/00337
PI21/00298
RD21/0017/0004
PI18/00330
PI17/00672Red TerAvJunta de Andalucia FEDER/European Cohesion Fund (FSE) for AndalusiaSpanish Government PI18/00337
PI21/00298European Union-NextGenerationEU - Maria Zambrano Senior Program RD21/0017/0004
PI18/00330
PI17/00672Ministry of Health 2016000073332-TRA
PI-57069
CARTPI-0001-201
PE-CART-0031-2020
PI-0014-2016
PECART-0027-2020
ProyExcel_00875
PEER-0286-2019European Cooperation in Science and Technology (COST) 00123009/SNEO-20191072MINECO - European Regional Development Fund PLEC2021-008094Spanish Government 0006/2018FEDER/Junta de Andalucia-Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades CA21113Spanish Government SAF2015-71589-PMCI RYC-2016-21395German Research Foundation (DFG) PY20_00619 y A-CTS-28_UGR20Biomedicine Program of the University of Granada (Spain) FPU16/05467
FPU17/02268
FPU17/04327
DIN2018-010180
DIN2020-011550
PEJ-2018-001760-
Correlation between clinical parameters characterising peri-implant and periodontal health : a practice-based research in Spain in a series of patients with implants installed 4-5 years ago
Objectives: To explore peri-implant health (and relation with periodontal status) 4-5 years after implant insertion. Study D esign: A practice-based dental research network multicentre study was performed in 11 Spanish centres. The first patient/month with implant insertion in 2004 was considered. Per patient four teeth (one per quadrant) showing the highest bone loss in the 2004 panoramic X-ray were selected for periodontal status assessment. Bone losses in implants were calculated as the differences between 2004 and 2009 bone levels in radiographs. Results: A total of 117 patients were included. Of the 408 teeth considered, 73 (17.9%) were lost in 2009 (losing risk: >50% for bone losses ?7mm). A total of 295 implants were reviewed. Eight of 117 (6.8%) patients had lost implants (13 of 295 implants installed; 4.4%). Implant loss rate (quadrant status) was 1.4% (edentulous), 3.6% (preserved teeth), and 11.1% (lost teeth) (p=0.037). The percentage of implant loss significantly (p<0.001) increased when the medial/distal bone loss was ?3 mm. The highest (p?0.001) pocket depths were found in teeth with ?5mm and implants with ?3mm bone losses, with similar mean values (?4mm), associated with higher rates of plaque index and bleeding by probing. Conclusions: The significant bi-directional relation between plaque and bone loss, and between each of these two parameters/signs and pocket depths or bleeding (both in teeth and implants, and between them) together with the higher percentage of implants lost when the bone loss of the associated teeth was ?3 mm suggest that the patient?s periodontal status is a critical issue in predicting implant health/lesion
Genetic diversity of HLA system in four populations from Baja California, Mexico: Mexicali, La Paz, Tijuana and rural Baja California
We studied HLA class I (HLA-A, -B) and class II (HLA-DRB1, -DQB1) alleles by PCR-SSP based typing in 250 Mexicans from the states of Baja California Norte and Baja California Sur living in Mexicali (N = 100), La Paz (N = 75), Tijuana (N = 25) and rural communities (N = 50) to obtain information regarding allelic and haplotypic frequencies. The most frequent haplotypes for the Baja California region include nine Native American and five European haplotypes. Admixture estimates revealed that the main genetic components are European (50.45 ± 1.84% by ML; 42.03% of European haplotypes) and Native American (43.72 ± 2.36% by ML; 40.24% of Native American haplotypes), while the African genetic component was less apparent (5.83 ± 0.98% by ML; 9.36% of African haplotypes)
POR UNA CULTURA DE PAZ: UNA MIRADA DESDE LAS CIENCIAS DE LA CONDUCTA
En
virtud
de
lo
anterior,
los
estudiosos
de
las
ciencias
de
la
conducta
de
la
Universidad
Autónoma
del
Estado
de
México,
ante
la
persistencia
y
proliferación
de
estos
hechos
en
diversas
partes
del
Mundo
y
de
nuestro
país
en
particular, se
convocó
a
los
estudiosos
interesados
y
a
la
sociedad
en
general
a
presentar
trabajos
para
analizar,
debatir
y
proponer
estrategias
de
acción
y
dirección,
que
fortalezcan
una
convivencia y bienestar con sentido humanista para una cultura de paz.
El
presente
texto
es
producto
de
esta convocatoria
que
recoge
los
trabajos
de
los
interesados
en
la
temática,
de
diferentes
países
(España,
Argentina,
Cuba,
Brasil,
Costa
Rica
y
México)
retomando
con
ello
sus
experiencias
relativas
al
estudio,
análisis,
comprensión
e
instrumentación
de
la
cultura
de
paz
en
los
distintos
ámbitos
institucionales
en
los
que
participan:
educativo,
salud,
penitenciario,
social,
laboral,
familia,
alimentario,
psicológico,
por
mencionar
algunos.
El
presente
libro,
propicia
un
espacio
de
reflexión,
diálogo
y
posicionamiento
de
las
ciencias
de
la
conducta
para
la
apropiación,
análisis,
debate
y
propuestas
que
fortalezcan
una
cultura
de
paz
a
través
de
la
convivencia
y
el
bienestar
social
con
sentido
humanista.
El
sistema
económico
neoliberal
y
el
proceso
de
globalización
han
contribuido
al
logro
de
avances
significativos
en
la
ciencia
y
la
tecnología,
pero
también
han
propiciado
la
polarización
de
las
sociedades
lo
que
ha
impactado
de
manera
negativa
a
la
sociedad
en
su
conjunto,
pero
en
mayor
medida
a
los grupos
vulnerables. Dicha
polarización
ha
traído
consigo
un
desarrollo
desigual
del
mundo
que
se
expresa
de
diferentes
maneras
tanto
en
países
desarrollados
como
en
los
llamados
del
tercer
mundo,
en
donde
no
están
satisfechas
las
necesidades
humanas
elementales
de
todos
los
sectores
de
la
población,
siempre
falta
algo.
Si
a
esto
le
sumamos
los
conflictos
internacionales por
diferentes
motivos
que
enfrentan
algunas
naciones,
una
insuficiente
cobertura
educativa
y
de
salud,
desempleo
y
pobreza
extrema,
entre
otras
cosas;
estamos
frente
a
retos
de
gran
envergadura
para
los
gobiernos,
para
los
estudiosos
y
para
la
sociedad
civil
en
general. Uno
de
los
intentos
para
frenar
y prevenir
la
agudización
de
estas
problemáticas
es
la
cultura
de
paz,
cuyo
estudio
y propuestas
han
ido
avanzando
en
diferentes
sentidos
y
de
manera
favorable,
el
tema
está
presente
en
diferentes
Organismos
Internacionales
como
la
ONU,
la
UNESCO,
la
OCDE,
El
Banco
Mundial,
entre
otros.
Pero
falta
mucho
por
hacer.Universidad Autónoma del Estado de Méxic
- …